Scientists from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression. Read more here.
Study mentioned: Dasgupta S, et al. Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR Signaling. Clin Cancer Res. 2013 Jul 19. [Epub ahead of print] PMID: 23873690
No comments:
Post a Comment